Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs, primarily in the realm of infectious diseases. The... Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs, primarily in the realm of infectious diseases. The company actively works on pioneering new treatments to combat antibiotic-resistant infections, recognizing the growing global challenge posed by these pathogens. Summit Therapeutics is notably involved in the research of novel antibiotic technologies and developing antibiotics with new mechanisms of action that aim to overcome current drug resistance issues. Their research extends to conditions such as C. difficile infection, a serious health threat in many healthcare settings. Through its commitment to innovation in the pharmaceutical industry, Summit Therapeutics has positioned itself as a key player in advancing medical solutions that are essential for improving public health outcomes. As part of the broader healthcare sector, Summit Therapeutics contributes to the ongoing efforts to curb the spread and impact of infectious diseases, which continues to be a critical focus in global health strategies.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Summit Therapeutics

We reviewed Summit Therapeutics's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Summit Therapeutics's data?

Create a free Tracenable account to signal interest in having our team review data for Summit Therapeutics.

Legal Center Contact Us